News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
PENDARVIS DAVID
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/30/2023 |
4
| PENDARVIS DAVID (Chief Administrative Officer) has filed a Form 4 on RESMED INC |
06/07/2023 |
4
| PENDARVIS DAVID (Chief Administrative Officer) has filed a Form 4 on RESMED INC
Txns:
| Sold 1,500 shares
@ $219.79, valued at
$329.7k
|
|
05/04/2023 |
4
| PENDARVIS DAVID (Chief Administrative Officer) has filed a Form 4 on RESMED INC
Txns:
| Sold 1,500 shares
@ $237.64, valued at
$356.5k
|
|
05/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
04/05/2023 |
4
| PENDARVIS DAVID (Chief Administrative Officer) has filed a Form 4 on RESMED INC
Txns:
| Sold 1,500 shares
@ $218.23, valued at
$327.3k
|
|
04/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
03/07/2023 |
4
| PENDARVIS DAVID (Chief Administrative Officer) has filed a Form 4 on RESMED INC
Txns:
| Sold 1,500 shares
@ $216.69, valued at
$325k
|
|
02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/05/2022 |
4
| PENDARVIS DAVID (Chief Administrative Officer) has filed a Form 4 on RESMED INC
Txns:
| Sold 1,545 shares
@ $220.19, valued at
$340.2k
|
|
09/07/2022 |
4
| PENDARVIS DAVID (Chief Administrative Officer) has filed a Form 4 on RESMED INC
Txns:
| Sold 1,545 shares
@ $216.92, valued at
$335.1k
|
|
08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/05/2022 |
4
| PENDARVIS DAVID (Chief Administrative Officer) has filed a Form 4 on RESMED INC
Txns:
| Sold 1,544 shares
@ $246.6, valued at
$380.8k
|
|
03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2022 |
4
| PENDARVIS DAVID (Chief Administration Officer) has filed a Form 4 on RESMED INC
Txns:
| Sold 1,544 shares
@ $258.52, valued at
$399.2k
|
|
12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/22/2021 |
4
| PENDARVIS DAVID (Chief Administration Officer) has filed a Form 4 on RESMED INC
Txns:
| Granted 5,931 options to buy
@ $263.16, valued at
$1.6M
|
|
11/18/2021 |
4
| PENDARVIS DAVID (Chief Administrative Officer) has filed a Form 4 on RESMED INC
Txns:
| Granted 17,307 shares
@ $254.81, valued at
$4.4M
Paid exercise price by delivering 9,655 shares
@ $254.81, valued at
$2.5M
Granted 986 shares
@ $0 |
|
11/15/2021 |
4
| PENDARVIS DAVID (Chief Administrative Officer) has filed a Form 4 on RESMED INC
Txns:
| Paid exercise price by delivering 1,549 shares
@ $259.47, valued at
$401.9k
Gifted 10,000 shares
@ $0 Exercised 983 options to buy
@ $101.64, valued at
$99.9k
|
|
11/05/2021 |
4
| PENDARVIS DAVID (Chief Administrative Officer) has filed a Form 4 on RESMED INC
Txns:
| Sold 1,485 shares
@ $264.29, valued at
$392.5k
|
|
10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|